| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |